openPR Logo
Press release

Wilm’s Tumor Market Projected to Garner Significant Revenues by 2024

07-12-2017 03:31 PM CET | Health & Medicine

Press release from: Persistence Market Research

Wilm’s Tumor Market Projected to Garner Significant Revenues

Wilm’s tumors often become large, averagely newly found Wilm’s tumor is larger than the kidney in which it is started. Common symptoms present in children are fever and bleeding during urination, abdominal swelling and abdominal pain. In present scenario, survival rate of children suffering from Wilm’s tumor is approximately 80% to 90%. Average age at diagnosis is about 3-4 years and is rare as children grow older and is uncommon after age 6.

Get access to full summary @: http://www.persistencemarketresearch.com/market-research/wilms-tumor-market.asp

Wilm’s tumor also called Nephroblastoma is a type of cancer that starts in the kidneys and is most common type of kidney cancer in children. The ratio of Wilm’s tumor is about 9 of 10 kidney cancers in children. Tumors which affects only one kidney and have only one tumor are unilateral. Around 5-10% of children with Wilm’s tumors have more than one tumor in same kidney. About 5% of children with Wilm’s tumors have tumors in both kidneys which means they have bilateral disease.

Technological advancement owing to rise in enhanced diagnostics and treatment therapies, increasing number of births per year are some of the factors which will drive the Wilm’s tumor market. In addition macro-economic factors like increasing expenditure on research and development to bring out novel therapies for Wilm’s tumor will drive this market in forecast period. Due to the high cost of treatment of therapies this can hamper the overall growth of the Wilm’s tumor market.

A Sample of this Report is Available Upon Request @ http://www.persistencemarketresearch.com/samples/10610

The incidence of Wilm’s tumor in children below 15 years is 7.1 cases per 1 million children. It is observed that Wilm’s tumor is slightly more in girls than boys and is especially in Africa and U.S. Factors such as increasing demand for diagnostic solutions and treatment therapies for Wilms tumor, Wilm’s tumor market is expected to have tremendous growth during the forecast period (2016-2026)

On the basis of region presence, abdominal aortic aneurysm treatment market is segmented into five key regions: North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.

Analyzing the present scenario North America dominates the global market for Wilms tumor followed by Europe due to the high incidence rate of Wilms tumor. According to the American Society of Cancer in 2015 about 500 new cases of Wilms tumor are diagnosed in the U.S. The Wilms tumor is relatively more in African countries while comparatively less in East Asia.

Request to View Tables of Content @ http://www.persistencemarketresearch.com/toc/10610

Many companies have their presence in this market while some of them have their drugs in the pipeline for clinical trials. Some of the key player in Wilm’s Tumor Market are Merck & Co.Inc, MediLexicon International Ltd, Bristol-Myers Squibb, APOTEX INC

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Wilm’s Tumor Market Projected to Garner Significant Revenues by 2024 here

News-ID: 621695 • Views:

More Releases from Persistence Market Research

North America Synthetic Opioids Market Growth Outlook: Valued at US$93.2 Billion in 2025, Expanding at 2.4% CAGR - Persistence Market Research
North America Synthetic Opioids Market Growth Outlook: Valued at US$93.2 Billion …
The North America synthetic opioids market is projected to reach a valuation of US$110.0 billion by 2032, expanding from US$93.2 billion in 2025 at a compound annual growth rate (CAGR) of 2.4% between 2025 and 2032. The market's expansion is primarily driven by the proliferation of fentanyl and its analogs-powerful synthetic opioids that have dramatically reshaped pain management, addiction treatment, and public health policy across the region. Synthetic opioids, particularly fentanyl,
Air Conditioning Compressor Market Projected to Reach US$ 41.1 Billion by 2032, Reports Persistence Market Research
Air Conditioning Compressor Market Projected to Reach US$ 41.1 Billion by 2032, …
The global Air Conditioning Compressor Market is entering a period of sustained growth, propelled by the increasing global demand for energy-efficient cooling solutions, rapid urbanization, and stringent environmental regulations. Valued at US$ 28.8 billion in 2025, the market is forecast to expand to US$ 41.1 billion by 2032, registering a compound annual growth rate (CAGR) of 5.2% between 2025 and 2032. Air conditioning compressors-considered the "heart" of HVAC systems-play a
U.S. Polycystic Ovarian Syndrome Treatment Market Growth Outlook: 7.2% CAGR Through 2032, Says Persistence Market Research
U.S. Polycystic Ovarian Syndrome Treatment Market Growth Outlook: 7.2% CAGR Thro …
The U.S. Polycystic Ovarian Syndrome (PCOS) Treatment Market is poised for significant expansion over the next decade, underpinned by growing awareness of the long-term metabolic and reproductive implications of PCOS. Valued at US$4.6 billion in 2025, the market is projected to reach US$7.5 billion by 2032, reflecting a CAGR of 7.2% between 2025 and 2032. This growth trajectory is supported by the rising prevalence of PCOS among American women, increasing
Electrostatic Chucks (ESCs) Market Poised to Hit US$ 3.2 Billion by 2032, Reports Persistence Market Research
Electrostatic Chucks (ESCs) Market Poised to Hit US$ 3.2 Billion by 2032, Report …
The global Electrostatic Chucks (ESCs) Market is witnessing remarkable expansion, driven by the surging demand for miniaturized semiconductor components and the advancement of high-performance wafer fabrication technologies. Valued at US$ 1.9 billion in 2025, the market is projected to reach US$ 3.2 billion by 2032, reflecting a CAGR of 7.6% during the forecast period (2025-2032). As semiconductor manufacturing continues to evolve toward greater precision, efficiency, and throughput, electrostatic chucks-vital for

All 5 Releases


More Releases for Wilm’s

Kidney Cancer Market Size, Competitive Analysis, Share, Forecast- 2018-2023
Global kidney cancer is one of the most common cancers across the globe. Most of the kidney cancers get diagnosed before they metastasize to distant organs. However, the tumours can grow to be quite large before they are detected. The global kidney cancer market is estimated to grow with the CAGR of 6.2% during 2018-2023. The growth of the market is attributed to increasing incidence of kidney cancers and
Global Kidney Cancer Market Trends, Size, Forecast - 2018-2023
Global kidney cancer is one of the most common cancers across the globe. Most of the kidney cancers get diagnosed before they metastasize to distant organs. However, the tumours can grow to be quite large before they are detected. The global kidney cancer market is estimated to grow with the CAGR of 6.2% during 2018-2023. The growth of the market is attributed to increasing incidence of kidney cancers and increasing
Kidney Cancer Market Trends, Size, Forecast 2018 - 2023
Global kidney cancer is one of the most common cancers across the globe. Most of the kidney cancers get diagnosed before they metastasize to distant organs. However, the tumours can grow to be quite large before they are detected. The global kidney cancer market is estimated to grow with the CAGR of 6.2% during 2018-2023. The growth of the market is attributed to increasing incidence of kidney cancers and
Wilm’s Tumor Market Revenue Predicted to Go Up by 2016 – 2024 : Persistence …
Wilm’s tumor also called Nephroblastoma is a type of cancer that starts in the kidneys and is most common type of kidney cancer in children. The ratio of Wilm’s tumor is about 9 of 10 kidney cancers in children. Tumors which affects only one kidney and have only one tumor are unilateral. Around 5-10% of children with Wilm’s tumors have more than one tumor in same kidney. About 5% of
Wilm’s Tumor Market Estimated to Grow Strongly by 2016 - 2024
Wilm’s tumor also called Nephroblastoma is a type of cancer that starts in the kidneys and is most common type of kidney cancer in children. The ratio of Wilm’s tumor is about 9 of 10 kidney cancers in children. Tumors which affects only one kidney and have only one tumor are unilateral. Around 5-10% of children with Wilm’s tumors have more than one tumor in same kidney. About 5% of
Future of Global Wilm’s Tumor Market 2016 - 2024
Wilm’s tumor also called Nephroblastoma is a type of cancer that starts in the kidneys and is most common type of kidney cancer in children. The ratio of Wilm’s tumor is about 9 of 10 kidney cancers in children. Tumors which affects only one kidney and have only one tumor are unilateral. Around 5-10% of children with Wilm’s tumors have more than one tumor in same kidney. About 5% of